Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Breast 3Genitourinary 2Tumor-Agnostic 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Breast Neoplasms 2Disease 1Breast Cancer Female 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Drug Delivery Systems × Breast × Clear all
NCT04257799 2022-06-22

Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

Dartmouth-Hitchcock Medical Center

Completed
100 enrolled
Breast

Breast Cancer Female

NCT02690805 2021-04-19

Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System

University of California, Irvine

Completed
16 enrolled
Breast

Breast Neoplasms

NCT01373671 2020-08-07

DBT

Siemens Medical Solutions USA - CSG

Phase NA Completed
764 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡